본문으로 건너뛰기

논문 검색

검색 결과 24,379 SQL fulltext 📄 CSV ↓ 📖 OA 100% 📄 PDF 20편
📖 출처 필터 (다중 토글 · 이 페이지 결과만)
📖 이 페이지: 20/20편 (100%) 무료 전문 가능 · 무료전문만 보기 →
  • Spatial transcriptomics unveils immune cellular ecosystems associated with patient survival in diffuse large B-cell lymphoma.
    Oncoimmunology 2026 Diaz-Herrero A 📖 Unpaywall unknown 🆕 신규 PMID: 42010788 ↗

    Diffuse large B-cell Lymphoma (DLBCL) is the most prevalent subtype of non-Hodgkin's lymphoma for which current therapeutic strategies remain insufficient, in part owing to heterogeneity in tumor biology and the immune microenvironment. The…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • activates histone lactylation to promote gastric cancer progression and immune evasion through the HAS2/c-MYC/PD-L1 axis.
    Gut microbes 2026 Chen H 📖 Unpaywall unknown 🆕 신규 PMID: 42021123 ↗

    [BACKGROUND] Metabolic reprogramming and epigenetic alterations play important roles in driving tumor microenvironment (TME) remodeling and immune evasion in gastric cancer (GC). Histone lactylation links glycolytic metabolism to transcript…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Downregulation of the lncRNA PGM5P4-AS1 predicts poor prognosis and drives breast cancer progression through miR-3664-5p/KLF9.
    Cancer biology & therapy 2026 Wu Y cited 1 🟢 PMC 🆕 신규 PMID: 41454916 ↗

    [BACKGROUND] Accumulating evidence suggests that deregulated long non-coding RNAs (lncRNAs) drive breast cancer (BRCA) progression. This study investigated the expression profile and mechanism of PGM5P4 antisense RNA 1 (PGM5P4-AS1) in BRCA.…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Passive nuclear transport deviates from Fickian behavior in prostate and breast cell types.
    Nucleus (Austin, Tex.) 2026 Scott NR 🟢 PMC 🆕 신규 PMID: 41618797 ↗

    Nuclear trafficking is essential for cellular function and biomedical applications such as nucleus-targeted drug delivery; however, how passive nuclear transport varies across cell types and phenotypic states remains poorly understood. Here…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • The role of copper and cuproptosis in digestive system cancers: novel therapeutic strategies and mechanistic insights.
    Cancer biology & therapy 2026 Xu G 🟢 PMC 🆕 신규 PMID: 41837409 ↗

    Recent research has highlighted the critical role of copper metabolism and a novel form of copper-dependent cell death, termed cuproptosis, in the progression and treatment of these cancers. Copper, an essential trace element, plays a cruci…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Dynamic changes in cellular mechanics and membrane microviscosity during migration of colorectal cancer cells.
    Cell cycle (Georgetown, Tex.) 2026 Shimolina L 🟢 PMC 🆕 신규 PMID: 41532524 ↗

    The ability of tumor cells to migrate and invade adjacent tissue is a key property underlying the metastatic process. To ensure greater deformability and to facilitate movement, migratory cells undergo multiple changes in biophysical parame…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • The interplay between autophagy, p16, and senescence in tumor cells: a systematic review.
    Cell cycle (Georgetown, Tex.) 2026 Palabiyik AA 🟢 PMC 🆕 신규 PMID: 41317088 ↗ 메타분석

    Autophagy and cellular senescence are fundamental determinants of tumor cell fate. p16 has emerged as a key regulator at the intersection of these processes, yet its mechanistic role in the autophagy - senescence axis remains incompletely d…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression.
    Journal of medical economics 2026 Shadman M 📖 Unpaywall unknown 🆕 신규 PMID: 41553230 ↗

    [BACKGROUND] Bruton tyrosine kinase inhibitors (BTKis) are therapeutic agents for relapsed/refractory chronic lymphocytic leukemia (R/R CLL). Previous indirect treatment comparisons are limited in simultaneously comparing multiple intervent…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • XPO1 Inhibition enhances sensitivity to platinum-based chemotherapy in germinal-center B-cell-like-DLBCL cells.
    Hematology (Amsterdam, Netherlands) 2026 Su Q 📖 Unpaywall unknown 🆕 신규 PMID: 41631406 ↗

    [PURPOSE] Platinum-based chemotherapy is considered as salvage therapy to relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients. However, treatment failure due to drug resistance occurs in some patients, particularly those with…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes.
    Hematology (Amsterdam, Netherlands) 2026 Matsukawa T 📖 Unpaywall CC BY 🆕 신규 PMID: 41666291 ↗

    [BACKGROUND] Secondary acute myeloid leukemia (sAML) and AML with myelodysplasia-related changes (AML-MRC) are associated with poor prognosis, but the impact relative to de novo AML remains controversial. We investigated clinical and geneti…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Phase angle as a nutritional assessment method in patients with acute myeloid leukemia: a cross-sectional study.
    Hematology (Amsterdam, Netherlands) 2026 Li W 📖 Unpaywall CC BY 🆕 신규 PMID: 41701098 ↗ 단면연구

    [BACKGROUND AND OBJECTIVES] The phase angle, which is associated with cellular health, has garnered increasing attention as a noninvasive and objective method for nutritional assessment. However, the association between malnutrition and pha…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Time to access matters: patient gains from faster CAR T-cell reimbursement in Europe.
    Journal of medical economics 2026 Tan YZ 📖 Unpaywall unknown 🆕 신규 PMID: 41705912 ↗

    [BACKGROUND] Despite clinical efficacy and cost-effectiveness, time to reimbursement for chimeric antigen receptor (CAR) T-cell therapies varies greatly across Europe. We examined these differences, and quantified potential patient benefits…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • The surgery for the patients with intestinal non‑Hodgkin lymphomas: a nationwide study.
    Annals of medicine 2026 Kim J 📖 Unpaywall CC BY 🆕 신규 PMID: 41732903 ↗

    [BACKGROUND] The treatment strategy for intestinal non-Hodgkin lymphoma (NHL) and the role of surgery warrant reevaluation. [METHODS] This study analyzed clinical data from a cohort of 12,047 patients diagnosed with intestinal NHL, extract…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Neural network reveals platelet age from fluorescence microscopy images.
    Platelets 2026 Slotman JA 📖 Unpaywall CC BY 🆕 신규 PMID: 41992909 ↗

    Platelets are small, anucleate cells with a primary physiological role in vascular damage repair (hemostasis) and initiation of thrombus formation in response to vascular injury. Platelets circulate approximately 7-10 days, slowly undergoin…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • NAD precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL.
    Pharmaceutical science advances 2026 Shi L 📖 Unpaywall CC BY-NC-ND 🆕 신규 PMID: 41993707 ↗

    Natural killer (NK) cells play a key role in the standard treatment of diffuse large B-cell lymphoma (DLBCL). However, NK cells in DLBCL patients frequently display an exhausted phenotype, which is associated with poor clinical outcomes. Th…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • A Randomized Trial Evaluating Intraoperative Ischemic Preconditioning of Parathyroid Glands During Total Thyroidectomy: A Signal for Earlier Parathyroid Function Recovery.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research 2026 Sheng Q 📖 Unpaywall unknown 🆕 신규 PMID: 41612903 ↗ 무작위 임상시험

    [BACKGROUND] Ischemic preconditioning of parathyroid glands (IPCP) is biologically plausible but clinical evidence is limited. In this single-center randomized trial (ChiCTR2000039788), we compared IPCP versus control during total thyroidec…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Integrating virtual screening and molecular dynamics simulations to identify emodin as a PYCR1 inhibitor modulating docetaxel sensitivity in prostate cancer.
    Journal of enzyme inhibition and medicinal chemistry 2026 Liu S 📖 Unpaywall unknown 🆕 신규 PMID: 41665114 ↗

    Docetaxel (DTX) resistance is the main cause of treatment failure in castration-resistant prostate cancer (CRPC). Pyrroline-5-carboxylic acid reductase 1 (PYCR1) is an enzyme involved in proline metabolism. It is highly expressed in various…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Incomplete thermal ablation accelerates local and systemic tumor progression in an immunocompetent prostate cancer model.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2026 Kader A 📖 Unpaywall CC BY 🆕 신규 PMID: 41813588 ↗

    [BACKGROUND] This study aims to evaluate the effects of sublethal hyperthermia on tumor growth of residual tumors in an immune-competent mouse model of prostate cancer. [MATERIALS AND METHODS] The study progressed through sequential experi…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Comparison of the effects of exercise-based interventions on cardiometabolic health and fatigue in men with prostate cancer receiving androgen deprivation therapy: A network meta-analysis.
    Asia-Pacific journal of oncology nursing 2026 Quan L 📖 Unpaywall CC BY-NC-ND 🆕 신규 PMID: 42022295 ↗ 메타분석

    [OBJECTIVE] To compare the effects of exercise-based interventions on cardiometabolic health and fatigue in men with prostate cancer receiving androgen deprivation therapy (ADT). [METHODS] A comprehensive search for Randomized controlled s…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome
  • Survival Outcome Was Better with Liver Resection than with Percutaneous Radiofrequency Ablation in Patients with Very Early-Stage Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research 2026 Yen YH 📖 Unpaywall unknown 🆕 신규 PMID: 41660702 ↗

    [BACKGROUND] Antiviral therapies for hepatitis B or C virus may be associated with reduced risk of tumor recurrence and mortality of patients with hepatocellular carcinoma (HCC) undergoing curative treatments, compared to untreated patients…

    FULLTEXT: Cellular Reprogramming randomized randomized outcome